LOG IN
Analysis
Featured Analysis
Articles by Category
Current Editions
Data Graphics
Discovery & Translation
Hot Topics
Podcasts & Webcasts
Special Reports & Presentations
White Papers
BCIQ Data
BCIQ
Company Profiles
Product Profiles
Target Profiles
Financial Dashboards
Events
All Events
BioCentury-BayHelix China Healthcare Summit
East-West Healthcare Reception
BioCentury-BayHelix East-West Summit
Bio€quity Europe
BioCentury Grand Rounds Inquiry
The BioCentury Show
Webinars - Upcoming & On-Demand
My Workspace
About BioCentury
Management
Analysts & Research Team
Scientific Advisory Board
Contact
Contact Us
Forgot Password
Request a Subscription
Sponsorship & Branding Inquiry
Media Kit
Request BioCentury's BCIQ Brochure
Customer Resource Center
Career Opportunities
Request a Trial
Company Profiles
Target Profiles
Product Profiles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Company Profiles
Target Profiles
Product Profiles
China Healthcare Summit
Bio€quity Europe
Explore BCIQ profiles by entering a company name.
REQUEST A FREE TRIAL
Overview
Pipeline
Deals
Financings
Articles
Franklin Biolabs Inc.
Headquarters:
Philadelphia, PA, United States of America
Website:
N/A
Year Founded:
2023
Status:
Private
BioCentury
|
Jan 3, 2025
Finance
Ausperbio, Gemmabio, Velavigo tap VCs for cash in late December
In BioCentury’s latest Venture Report, two trans-Pacific companies and a gene therapy newco draw funding
Read More
BioCentury
|
Aug 13, 2024
Product Development
Wilson’s gene therapy vision. Plus: Korea biotech & Grand Rounds — a BioCentury podcast
Why gene therapies will extend beyond rare genetic diseases. Korean biotech on the rise. Grand Rounds conference ready for debut
Read More
BioCentury
|
Aug 9, 2024
Product Development
From rare to ultrarare to prevalent: Jim Wilson on gene therapy’s future
BioCentury’s Q&A with Jim Wilson, AAV pioneer and founder of GemmaBio and Franklin Biolabs
Read More
BioCentury
|
Aug 7, 2024
Product Development
Jim Wilson’s move to industry is anchored in global vision for ultrarare diseases
Gene therapy pioneer tells BioCentury his plans for his newcos GemmaBio and Franklin Biolabs
Read More
Items per page:
10
1 - 4 of 4